Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
Pfizer on Tuesday reported fourth-quarter results that topped estimates even amid dwindling demand for its Covid products, while reaffirming its
Read More
Author: Business Investor
Why Optimism Could Be the Most Profitable Strategy of 2026
Editor’s Note: One of the hardest things to do as an investor is stay constructive when markets feel noisy, crowded,
Read More
Trump: If states can’t run elections ‘honestly,’ then ‘somebody else should take over’
President Donald Trump sits at his desk, behind a hat that reads “America is back” at the White House in
Read More
If you missed big international stock market rally in 2025, it’s not too late to start
After spending most of the past decade being trounced by the U.S. stock market, international equities are back and investing
Read More
Uber reports 20% revenue growth in fourth-quarter, but issues soft profit guidance
Uber reported better-than-expected revenue in its fourth-quarter earnings report on Wednesday, but the company issued soft profit guidance for the
Read More
PepsiCo’s drink sales are improving, and it’s planning to cut snack prices
PepsiCo on Tuesday reported quarterly earnings and revenue that topped analysts’ expectations, fueled by improving organic sales across its business. Demand for
Read More
Defense Drone Stocks: Inside the Next Supercycle
The infrastructure of future conflicts is being built now. The stocks that dominate headlines — from the Magnificent 7 to
Read More
Trump signs bill ending federal government shutdown
President Donald Trump on Tuesday signed a bill into law to reopen most of the government, officially ending a partial
Read More
American Express, credit card provider to the wealthy, wants even more high spenders
American Express announces the new platinum business card. Courtesy: American Express American Express is finding that even for a provider
Read More
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro
Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its
Read More